The Global Burden of Disease projects: What have we learned about illicit drug use and dependence and their contribution to the global burden of disease?

Drug and Alcohol Review

Volumn 33, Issue 1, 2014, Pages 4-12

  Degenhardt, Louisa ^a,b   Whiteford, Harvey ^c   Hall, Wayne D ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Burden of disease; Dependence; Epidemiology; Illicit drugs

Indexed keywords

COST OF ILLNESS; FEMALE; HUMAN; INTERNATIONAL COOPERATION; MALE; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

COST OF ILLNESS; FEMALE; HUMANS; INTERNATIONALITY; MALE; RISK ASSESSMENT; SUBSTANCE-RELATED DISORDERS;

EID: 84891959728     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12088     Document Type: Note

References (36)

1. Lopez AD. The evolution of the global burden of disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Global Health 2005;1:5. doi:10.1186/1744-8603-1-5.
2. Prince M, Patel V, Saxena S, etal. No health without mental health. Lancet 2007;370:859-877.
3. Murray CJ, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Boston, MA: Harvard University Press, 1996.
4. Ustun T, Ayuso-Mateos J, Chatterji S, Mathers C, Murray C. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-392.
5. Lim SS, Vos T, Flaxman AD, etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260.
6. Lozano R, Naghavi M, Foreman K, etal. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.
7. Murray CJL, Vos T, Lozano R, etal. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223.
8. Salomon JA, Vos T, Hogan DR, etal. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012;380:2129-2143.
9. Vos T, Flaxman AD, Naghavi M, etal. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163-2196.
10. Degenhardt L, Whiteford H, Ferrari AJ, etal. The global burden of disease attributable to illicit drug use and dependence: results from the GBD 2010 study. Lancet 2013. doi: 10.1016/S0140-6736(13)61530-5.
11. Whiteford HA, Degenhardt L, Rehm J, etal. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013. doi: pii: S0140-6736(13)61611-6. Epub ahead of print.
12. Murray CJL, Lopez AD. Regional patterns of disability-free life expectancy and disability adjusted life expectancy: Global Burden of Disease Study. Lancet 1997;349:1347-1352.
13. World Bank. World development report 1993: investing in health. New York: Oxford University Press, 1993.
14. Bobadilla JL, Cowley P, Musgrove P, Saxenian H. Design, content and financing of an essential national package of health services. In: Murray CJL, Lopez AD, eds. Global comparative assessments in the health sector: disease burden, expenditures and intervention packages. Geneva: World Health Organization, 1994:171-180.
15. Chisholm D, on behalf of WHO-CHOICE. Choosing cost-effective interventions in psychiatry: results from CHOICE programme of the World Health Organization. World Psychiatry 2005;4:37-44.
16. Jamison DT, Breman JG, Measham AR, etal., eds. Disease control priorities in developing countries, Second edn. New York: Oxford University Press, 2006.
17. World Health Organization. The world health report 2008: primary health care now more than ever. Geneva: World Health Organization, 2008.
18. Lopez AD, Mathers C, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757.
19. Degenhardt L, Bucello C, Calabria B, etal. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 2011;117:85-101.
20. Calabria B, Degenhardt L, Briegleb C, etal. Systematic reviews of prospective studies investigating 'remission' from amphetamine, cannabis, cocaine and opioid dependence. Addict Behav 2010;35:741-749.
21. Degenhardt L, Bucello C, Mathers B, etal. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011;106:32-51.
22. Calabria B, Degenhardt L, Hall W, Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 2010;29:318-330.
23. Singleton J, Degenhardt L, Hall W, Zabransky T. Mortality among people who use amphetamines: a systematic review of cohort studies. Drug Alcohol Depend 2009;105:1-8.
24. Degenhardt L, Singleton J, Calabria B, etal. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 2011;113:88-95.
25. Degenhardt L, Ferrari AJ, Calabria B, etal. The global epidemiology and contribution of cannabis use and dependence to the Global Burden of Disease: results from the GBD 2010 Study. PLoS One 2013;8:10, e76635. doi: 10.1371/journal.pone.0076635.
26. Babor TF, Caulkins J, Edwards G, etal., eds. Drug policy and the public good. Oxford: Oxford University Press, 2010.
27. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70.
28. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR, 2007.
29. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
30. Stuckler D, King L, Robinson H, McKee M. WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet 2008;372:1563-1569.
31. Lopez A. Health and health-research priorities: has WHO got it right? Lancet 2008;372:1525.
32. Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2006;3:e442.
33. Abbadi K. The World Bank and world health: Healthcare strategy. BMJ 1999;318:933-936.
34. Ebrahim S, Smeeth L. Non-communicable diseases in low and middle income countries: a priority or a distraction? Int J Epidemiol 2003;34:961-966.
35. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013;310:591-608.
36. Murray CJ, Richards MA, Newton JN, etal. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013;381:997-1020.